Detecting albendazole metabolites in serum and urine: a first step in developing an indicator of MDA compliance in humans

Autores
Ceballos, Laura; Cimino, Rubén Oscar; Juarez, Marisa del Valle; Moreno Torrejon, Laura; Banal, Juan Pablo; Alvarez, Luis Ignacio; Krolewiecki, Alejandro Javier; Walson, Judd; Lanusse, Carlos Edmundo
Año de publicación
2017
Idioma
inglés
Tipo de recurso
documento de conferencia
Estado
versión publicada
Descripción
The neglected tropical diseases (NTDs) are a group of pathogens affecting individuals in the poorest regions of the world. Among them, Soil Transmitted Helminth (STH) infections directly impact nutritional status, educational development, individual productivity, and physical and mental development in human populations. Currently, these infections are controlled through mass drug administration (MDA) programs using albendazole (ABZ) or mebendazole. However, not all programs have demonstrated expected impact on prevalence or intensity of infections. These failures may be related to poor programmatic coverage, suboptimal adherence or the exposure of parasites to sub-therapeutic drug concentrations due to poor drug dissolution, insufficient gastrointestinal absorption and/or systemic availability of the active ingredient. Accordingly, improved knowledge of the basic pharmaco-kinetics of ABZ in treated people is critical. As part of the DeWorm3 project, we sought to characterize the serum disposition kinetics and pattern of urinary excretion of ABZ and its main metabolites (ABZ sulphoxide (ABZSO) and ABZ sulphone (ABZSO2)) in non-infected human volunteers. In addition, we sought to determine the duration and optimal timepoint where ABZ and/or its metabolites can be measured in urine as an indirect assessment of an individual?s adherence to treatment. Consecutive venous blood and urine samples were collected from eight (8) healthy volunteers between 2 and 72 h (serum) and 4 and 72 h (urine) for HPLC analysis of ABZ/metabolites following administration of a single postprandial oral dose of ABZ (400 mg Glaxo SmithKline).The ABZSO metabolite was the main analyte recovered either in serum and urine samples from ABZ-treated human. ABZSO serum concentrations reached its peak concentration (Cmax= 1.20 ± 0.44 μg/mL) at 4.75 h post-treatment. In urine ABZSO Cmax value was 3.24 ± 1.51 μg/mL, reached at 6.50 h post ABZ administration. The urinary AUC value, resulted higher (2.3 fold) compared to that measured in serum. The overall, PK-based information reported here demonstrates that the measurement of ABZSO concentrations both in serum and urine could be useful to confirm compliance to ABZ treatment and an objective measurement of program coverage.
Fil: Ceballos, Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tandil. Centro de Investigación Veterinaria de Tandil. Universidad Nacional del Centro de la Provincia de Buenos Aires. Centro de Investigación Veterinaria de Tandil. Provincia de Buenos Aires. Gobernación. Comision de Investigaciones Científicas. Centro de Investigación Veterinaria de Tandil; Argentina
Fil: Cimino, Rubén Oscar. Universidad Nacional de Salta. Sede Regional Orán. Instituto de Investigación de Enfermedades Tropicales; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Juarez, Marisa del Valle. Universidad Nacional de Salta. Sede Regional Orán. Instituto de Investigación de Enfermedades Tropicales; Argentina
Fil: Moreno Torrejon, Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tandil. Centro de Investigación Veterinaria de Tandil. Universidad Nacional del Centro de la Provincia de Buenos Aires. Centro de Investigación Veterinaria de Tandil. Provincia de Buenos Aires. Gobernación. Comision de Investigaciones Científicas. Centro de Investigación Veterinaria de Tandil; Argentina
Fil: Banal, Juan Pablo. Universidad Nacional de Salta. Sede Regional Orán. Instituto de Investigación de Enfermedades Tropicales; Argentina
Fil: Alvarez, Luis Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tandil. Centro de Investigación Veterinaria de Tandil. Universidad Nacional del Centro de la Provincia de Buenos Aires. Centro de Investigación Veterinaria de Tandil. Provincia de Buenos Aires. Gobernación. Comision de Investigaciones Científicas. Centro de Investigación Veterinaria de Tandil; Argentina
Fil: Krolewiecki, Alejandro Javier. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Salta. Sede Regional Orán. Instituto de Investigación de Enfermedades Tropicales; Argentina
Fil: Walson, Judd. Natural History Museum; Reino Unido
Fil: Lanusse, Carlos Edmundo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tandil. Centro de Investigación Veterinaria de Tandil. Universidad Nacional del Centro de la Provincia de Buenos Aires. Centro de Investigación Veterinaria de Tandil. Provincia de Buenos Aires. Gobernación. Comision de Investigaciones Científicas. Centro de Investigación Veterinaria de Tandil; Argentina
66° Annual Meeting of American Society of Tropical Medicine and Hygiene
Baltimore
Estados Unidos
American Society of Tropical Medicine and Hygiene
Materia
ALBENDAZOLE
PHARMACOKINETICS
HUMAN
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/174680
Acceder
id CONICETDig_e4bfac3e8467b188e46f8c351da9f3e3
oai_identifier_str oai:ri.conicet.gov.ar:11336/174680
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Detecting albendazole metabolites in serum and urine: a first step in developing an indicator of MDA compliance in humansCeballos, LauraCimino, Rubén OscarJuarez, Marisa del ValleMoreno Torrejon, LauraBanal, Juan PabloAlvarez, Luis IgnacioKrolewiecki, Alejandro JavierWalson, JuddLanusse, Carlos EdmundoALBENDAZOLEPHARMACOKINETICSHUMANhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3The neglected tropical diseases (NTDs) are a group of pathogens affecting individuals in the poorest regions of the world. Among them, Soil Transmitted Helminth (STH) infections directly impact nutritional status, educational development, individual productivity, and physical and mental development in human populations. Currently, these infections are controlled through mass drug administration (MDA) programs using albendazole (ABZ) or mebendazole. However, not all programs have demonstrated expected impact on prevalence or intensity of infections. These failures may be related to poor programmatic coverage, suboptimal adherence or the exposure of parasites to sub-therapeutic drug concentrations due to poor drug dissolution, insufficient gastrointestinal absorption and/or systemic availability of the active ingredient. Accordingly, improved knowledge of the basic pharmaco-kinetics of ABZ in treated people is critical. As part of the DeWorm3 project, we sought to characterize the serum disposition kinetics and pattern of urinary excretion of ABZ and its main metabolites (ABZ sulphoxide (ABZSO) and ABZ sulphone (ABZSO2)) in non-infected human volunteers. In addition, we sought to determine the duration and optimal timepoint where ABZ and/or its metabolites can be measured in urine as an indirect assessment of an individual?s adherence to treatment. Consecutive venous blood and urine samples were collected from eight (8) healthy volunteers between 2 and 72 h (serum) and 4 and 72 h (urine) for HPLC analysis of ABZ/metabolites following administration of a single postprandial oral dose of ABZ (400 mg Glaxo SmithKline).The ABZSO metabolite was the main analyte recovered either in serum and urine samples from ABZ-treated human. ABZSO serum concentrations reached its peak concentration (Cmax= 1.20 ± 0.44 μg/mL) at 4.75 h post-treatment. In urine ABZSO Cmax value was 3.24 ± 1.51 μg/mL, reached at 6.50 h post ABZ administration. The urinary AUC value, resulted higher (2.3 fold) compared to that measured in serum. The overall, PK-based information reported here demonstrates that the measurement of ABZSO concentrations both in serum and urine could be useful to confirm compliance to ABZ treatment and an objective measurement of program coverage.Fil: Ceballos, Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tandil. Centro de Investigación Veterinaria de Tandil. Universidad Nacional del Centro de la Provincia de Buenos Aires. Centro de Investigación Veterinaria de Tandil. Provincia de Buenos Aires. Gobernación. Comision de Investigaciones Científicas. Centro de Investigación Veterinaria de Tandil; ArgentinaFil: Cimino, Rubén Oscar. Universidad Nacional de Salta. Sede Regional Orán. Instituto de Investigación de Enfermedades Tropicales; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Juarez, Marisa del Valle. Universidad Nacional de Salta. Sede Regional Orán. Instituto de Investigación de Enfermedades Tropicales; ArgentinaFil: Moreno Torrejon, Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tandil. Centro de Investigación Veterinaria de Tandil. Universidad Nacional del Centro de la Provincia de Buenos Aires. Centro de Investigación Veterinaria de Tandil. Provincia de Buenos Aires. Gobernación. Comision de Investigaciones Científicas. Centro de Investigación Veterinaria de Tandil; ArgentinaFil: Banal, Juan Pablo. Universidad Nacional de Salta. Sede Regional Orán. Instituto de Investigación de Enfermedades Tropicales; ArgentinaFil: Alvarez, Luis Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tandil. Centro de Investigación Veterinaria de Tandil. Universidad Nacional del Centro de la Provincia de Buenos Aires. Centro de Investigación Veterinaria de Tandil. Provincia de Buenos Aires. Gobernación. Comision de Investigaciones Científicas. Centro de Investigación Veterinaria de Tandil; ArgentinaFil: Krolewiecki, Alejandro Javier. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Salta. Sede Regional Orán. Instituto de Investigación de Enfermedades Tropicales; ArgentinaFil: Walson, Judd. Natural History Museum; Reino UnidoFil: Lanusse, Carlos Edmundo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tandil. Centro de Investigación Veterinaria de Tandil. Universidad Nacional del Centro de la Provincia de Buenos Aires. Centro de Investigación Veterinaria de Tandil. Provincia de Buenos Aires. Gobernación. Comision de Investigaciones Científicas. Centro de Investigación Veterinaria de Tandil; Argentina66° Annual Meeting of American Society of Tropical Medicine and HygieneBaltimoreEstados UnidosAmerican Society of Tropical Medicine and HygieneAmerican Society of Tropical Medicine and Hygiene2017info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectReuniónBookhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/mswordapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfhttp://hdl.handle.net/11336/174680Detecting albendazole metabolites in serum and urine: a first step in developing an indicator of MDA compliance in humans; 66° Annual Meeting of American Society of Tropical Medicine and Hygiene; Baltimore; Estados Unidos; 2017; 166-166CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.astmh.org/ASTMH/media/2017-Annual-Meeting/ASTMH-2017-Abstract-Book.pdfinfo:eu-repo/semantics/altIdentifier/url/https://www.astmh.org/annual-meeting/past-meetingsInternacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:06:37Zoai:ri.conicet.gov.ar:11336/174680instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:06:37.282CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Detecting albendazole metabolites in serum and urine: a first step in developing an indicator of MDA compliance in humans
title Detecting albendazole metabolites in serum and urine: a first step in developing an indicator of MDA compliance in humans
spellingShingle Detecting albendazole metabolites in serum and urine: a first step in developing an indicator of MDA compliance in humans
Ceballos, Laura
ALBENDAZOLE
PHARMACOKINETICS
HUMAN
title_short Detecting albendazole metabolites in serum and urine: a first step in developing an indicator of MDA compliance in humans
title_full Detecting albendazole metabolites in serum and urine: a first step in developing an indicator of MDA compliance in humans
title_fullStr Detecting albendazole metabolites in serum and urine: a first step in developing an indicator of MDA compliance in humans
title_full_unstemmed Detecting albendazole metabolites in serum and urine: a first step in developing an indicator of MDA compliance in humans
title_sort Detecting albendazole metabolites in serum and urine: a first step in developing an indicator of MDA compliance in humans
dc.creator.none.fl_str_mv Ceballos, Laura
Cimino, Rubén Oscar
Juarez, Marisa del Valle
Moreno Torrejon, Laura
Banal, Juan Pablo
Alvarez, Luis Ignacio
Krolewiecki, Alejandro Javier
Walson, Judd
Lanusse, Carlos Edmundo
author Ceballos, Laura
author_facet Ceballos, Laura
Cimino, Rubén Oscar
Juarez, Marisa del Valle
Moreno Torrejon, Laura
Banal, Juan Pablo
Alvarez, Luis Ignacio
Krolewiecki, Alejandro Javier
Walson, Judd
Lanusse, Carlos Edmundo
author_role author
author2 Cimino, Rubén Oscar
Juarez, Marisa del Valle
Moreno Torrejon, Laura
Banal, Juan Pablo
Alvarez, Luis Ignacio
Krolewiecki, Alejandro Javier
Walson, Judd
Lanusse, Carlos Edmundo
author2_role author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv ALBENDAZOLE
PHARMACOKINETICS
HUMAN
topic ALBENDAZOLE
PHARMACOKINETICS
HUMAN
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv The neglected tropical diseases (NTDs) are a group of pathogens affecting individuals in the poorest regions of the world. Among them, Soil Transmitted Helminth (STH) infections directly impact nutritional status, educational development, individual productivity, and physical and mental development in human populations. Currently, these infections are controlled through mass drug administration (MDA) programs using albendazole (ABZ) or mebendazole. However, not all programs have demonstrated expected impact on prevalence or intensity of infections. These failures may be related to poor programmatic coverage, suboptimal adherence or the exposure of parasites to sub-therapeutic drug concentrations due to poor drug dissolution, insufficient gastrointestinal absorption and/or systemic availability of the active ingredient. Accordingly, improved knowledge of the basic pharmaco-kinetics of ABZ in treated people is critical. As part of the DeWorm3 project, we sought to characterize the serum disposition kinetics and pattern of urinary excretion of ABZ and its main metabolites (ABZ sulphoxide (ABZSO) and ABZ sulphone (ABZSO2)) in non-infected human volunteers. In addition, we sought to determine the duration and optimal timepoint where ABZ and/or its metabolites can be measured in urine as an indirect assessment of an individual?s adherence to treatment. Consecutive venous blood and urine samples were collected from eight (8) healthy volunteers between 2 and 72 h (serum) and 4 and 72 h (urine) for HPLC analysis of ABZ/metabolites following administration of a single postprandial oral dose of ABZ (400 mg Glaxo SmithKline).The ABZSO metabolite was the main analyte recovered either in serum and urine samples from ABZ-treated human. ABZSO serum concentrations reached its peak concentration (Cmax= 1.20 ± 0.44 μg/mL) at 4.75 h post-treatment. In urine ABZSO Cmax value was 3.24 ± 1.51 μg/mL, reached at 6.50 h post ABZ administration. The urinary AUC value, resulted higher (2.3 fold) compared to that measured in serum. The overall, PK-based information reported here demonstrates that the measurement of ABZSO concentrations both in serum and urine could be useful to confirm compliance to ABZ treatment and an objective measurement of program coverage.
Fil: Ceballos, Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tandil. Centro de Investigación Veterinaria de Tandil. Universidad Nacional del Centro de la Provincia de Buenos Aires. Centro de Investigación Veterinaria de Tandil. Provincia de Buenos Aires. Gobernación. Comision de Investigaciones Científicas. Centro de Investigación Veterinaria de Tandil; Argentina
Fil: Cimino, Rubén Oscar. Universidad Nacional de Salta. Sede Regional Orán. Instituto de Investigación de Enfermedades Tropicales; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Juarez, Marisa del Valle. Universidad Nacional de Salta. Sede Regional Orán. Instituto de Investigación de Enfermedades Tropicales; Argentina
Fil: Moreno Torrejon, Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tandil. Centro de Investigación Veterinaria de Tandil. Universidad Nacional del Centro de la Provincia de Buenos Aires. Centro de Investigación Veterinaria de Tandil. Provincia de Buenos Aires. Gobernación. Comision de Investigaciones Científicas. Centro de Investigación Veterinaria de Tandil; Argentina
Fil: Banal, Juan Pablo. Universidad Nacional de Salta. Sede Regional Orán. Instituto de Investigación de Enfermedades Tropicales; Argentina
Fil: Alvarez, Luis Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tandil. Centro de Investigación Veterinaria de Tandil. Universidad Nacional del Centro de la Provincia de Buenos Aires. Centro de Investigación Veterinaria de Tandil. Provincia de Buenos Aires. Gobernación. Comision de Investigaciones Científicas. Centro de Investigación Veterinaria de Tandil; Argentina
Fil: Krolewiecki, Alejandro Javier. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Salta. Sede Regional Orán. Instituto de Investigación de Enfermedades Tropicales; Argentina
Fil: Walson, Judd. Natural History Museum; Reino Unido
Fil: Lanusse, Carlos Edmundo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tandil. Centro de Investigación Veterinaria de Tandil. Universidad Nacional del Centro de la Provincia de Buenos Aires. Centro de Investigación Veterinaria de Tandil. Provincia de Buenos Aires. Gobernación. Comision de Investigaciones Científicas. Centro de Investigación Veterinaria de Tandil; Argentina
66° Annual Meeting of American Society of Tropical Medicine and Hygiene
Baltimore
Estados Unidos
American Society of Tropical Medicine and Hygiene
description The neglected tropical diseases (NTDs) are a group of pathogens affecting individuals in the poorest regions of the world. Among them, Soil Transmitted Helminth (STH) infections directly impact nutritional status, educational development, individual productivity, and physical and mental development in human populations. Currently, these infections are controlled through mass drug administration (MDA) programs using albendazole (ABZ) or mebendazole. However, not all programs have demonstrated expected impact on prevalence or intensity of infections. These failures may be related to poor programmatic coverage, suboptimal adherence or the exposure of parasites to sub-therapeutic drug concentrations due to poor drug dissolution, insufficient gastrointestinal absorption and/or systemic availability of the active ingredient. Accordingly, improved knowledge of the basic pharmaco-kinetics of ABZ in treated people is critical. As part of the DeWorm3 project, we sought to characterize the serum disposition kinetics and pattern of urinary excretion of ABZ and its main metabolites (ABZ sulphoxide (ABZSO) and ABZ sulphone (ABZSO2)) in non-infected human volunteers. In addition, we sought to determine the duration and optimal timepoint where ABZ and/or its metabolites can be measured in urine as an indirect assessment of an individual?s adherence to treatment. Consecutive venous blood and urine samples were collected from eight (8) healthy volunteers between 2 and 72 h (serum) and 4 and 72 h (urine) for HPLC analysis of ABZ/metabolites following administration of a single postprandial oral dose of ABZ (400 mg Glaxo SmithKline).The ABZSO metabolite was the main analyte recovered either in serum and urine samples from ABZ-treated human. ABZSO serum concentrations reached its peak concentration (Cmax= 1.20 ± 0.44 μg/mL) at 4.75 h post-treatment. In urine ABZSO Cmax value was 3.24 ± 1.51 μg/mL, reached at 6.50 h post ABZ administration. The urinary AUC value, resulted higher (2.3 fold) compared to that measured in serum. The overall, PK-based information reported here demonstrates that the measurement of ABZSO concentrations both in serum and urine could be useful to confirm compliance to ABZ treatment and an objective measurement of program coverage.
publishDate 2017
dc.date.none.fl_str_mv 2017
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/conferenceObject
Reunión
Book
http://purl.org/coar/resource_type/c_5794
info:ar-repo/semantics/documentoDeConferencia
status_str publishedVersion
format conferenceObject
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/174680
Detecting albendazole metabolites in serum and urine: a first step in developing an indicator of MDA compliance in humans; 66° Annual Meeting of American Society of Tropical Medicine and Hygiene; Baltimore; Estados Unidos; 2017; 166-166
CONICET Digital
CONICET
url http://hdl.handle.net/11336/174680
identifier_str_mv Detecting albendazole metabolites in serum and urine: a first step in developing an indicator of MDA compliance in humans; 66° Annual Meeting of American Society of Tropical Medicine and Hygiene; Baltimore; Estados Unidos; 2017; 166-166
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.astmh.org/ASTMH/media/2017-Annual-Meeting/ASTMH-2017-Abstract-Book.pdf
info:eu-repo/semantics/altIdentifier/url/https://www.astmh.org/annual-meeting/past-meetings
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/msword
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/pdf
dc.coverage.none.fl_str_mv Internacional
dc.publisher.none.fl_str_mv American Society of Tropical Medicine and Hygiene
publisher.none.fl_str_mv American Society of Tropical Medicine and Hygiene
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269966455275520
score 13.13397

Publicaciones similares